chr1-112667143-T-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006135.3(CAPZA1):c.655T>A(p.Ser219Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000625 in 1,600,456 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S219L) has been classified as Likely benign.
Frequency
Consequence
NM_006135.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPZA1 | NM_006135.3 | c.655T>A | p.Ser219Thr | missense_variant, splice_region_variant | 8/10 | ENST00000263168.4 | NP_006126.1 | |
CAPZA1 | XM_017002424.3 | c.655T>A | p.Ser219Thr | missense_variant, splice_region_variant | 8/10 | XP_016857913.1 | ||
CAPZA1 | XM_011542225.4 | c.*87T>A | splice_region_variant | 9/9 | XP_011540527.1 | |||
CAPZA1 | XM_011542225.4 | c.*87T>A | 3_prime_UTR_variant | 9/9 | XP_011540527.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPZA1 | ENST00000263168.4 | c.655T>A | p.Ser219Thr | missense_variant, splice_region_variant | 8/10 | 1 | NM_006135.3 | ENSP00000263168.3 | ||
CAPZA1 | ENST00000466066.1 | n.521T>A | splice_region_variant, non_coding_transcript_exon_variant | 2/4 | 2 | |||||
CAPZA1 | ENST00000476820.1 | n.224T>A | splice_region_variant, non_coding_transcript_exon_variant | 1/2 | 3 | |||||
CAPZA1 | ENST00000476936.5 | n.410T>A | splice_region_variant, non_coding_transcript_exon_variant | 6/8 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152256Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000722 AC: 18AN: 249172Hom.: 0 AF XY: 0.0000519 AC XY: 7AN XY: 134838
GnomAD4 exome AF: 0.0000628 AC: 91AN: 1448200Hom.: 1 Cov.: 26 AF XY: 0.0000624 AC XY: 45AN XY: 721252
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2022 | The c.655T>A (p.S219T) alteration is located in exon 8 (coding exon 8) of the CAPZA1 gene. This alteration results from a T to A substitution at nucleotide position 655, causing the serine (S) at amino acid position 219 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at